Healio’s top ophthalmology items so far in August include the FDA approval of Izervay for geographic atrophy and phase 3 results of OCS-01 eye drops for the treatment of inflammation and pain after cataract surgery.
Check out these items and more below.
Izervay receives FDA approval for geographic atrophy
The FDA approved Izervay, a complement C5 inhibitor, for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Astellas Pharma. Read more.
Burden of geographic atrophy high on patients, caregivers
SEATTLE — In the U.S. and